Aptamer-engineered nanomaterials offer several advantages, including reduced cytotoxicity, enhanced stability, improved selectivity/sensitivity, and the versatility to expand into various biomedical applications.

Genicore Biotech will be attending the 6th Global Conference on Biomedical Engineering (GCBME), the Taiwan Society of Biomedical Engineering (TSBME) Annual Meeting, and the Taiwan Society of Biomechanics (TSB) Annual Meeting at National Cheng Kung University in Tainan City from November 1 to 3, 2024.

Genicore Biotech will be attending 2024 MEDICAL JAPAN TOKYO at Makuhari Messe in Chiba, Tokyo, Japan, from October 9th to October 11th, 2024.